Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
SciBase Holding. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
SciBase Holding's earnings available for a low price, and how does
this compare to other companies in the same industry?
SciBase Holding is not considered high growth as it is expected to be loss making for the next 1-3 years.
SciBase Holding's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
SciBase Holding's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Simon Grant serves as the Chief Executive Officer of SciBase Holding AB and has been its President since 2014. Mr. Grant served as Chief Executive Officer of Neoventa Medical AB. He has extensive experience within the medical device industry, especially with diagnostic devices where he has focused on commercialization of new clinical technologies. He has held senior positions within management and sales and marketing in medtech startups such as Synectics Medical and Neoventa and in established multinationals such as Medtronic. He has always worked with an international focus and has been based in Scandinavia, the US and Asia.
Simon's compensation has increased whilst company is loss making.
Simon's remuneration is about average for companies of similar size in Sweden.
Management Team Tenure
Average tenure and age of the
management team in years:
The tenure for the SciBase Holding management team is about average.
CEO & President
Chief Financial Officer
Head of Business Development & Marketing
Global Sales Director
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the SciBase Holding board of directors is about average.
Easy Come, Easy Go: How SciBase Holding (STO:SCIB) Shareholders Got Unlucky And Saw 85% Of Their Cash Evaporate
While it may not be enough for some shareholders, we think it is good to see the SciBase Holding AB (publ) (STO:SCIB) share price up 13% in a single quarter. … Investors will be hoping that SciBase Holding can make progress and gain better traction for the business, before it runs low on cash. … SciBase Holding has already given some investors a taste of the bitter losses that high risk investing can cause.
Do Insiders Own Lots Of Shares In SciBase Holding AB (publ) (STO:SCIB)?
Every investor in SciBase Holding AB (publ) (STO:SCIB) should be aware of the most powerful shareholder groups. … SciBase Holding is not a large company by global standards. … See our latest analysis for SciBase Holding
What Do Analysts Think About SciBase Holding AB (publ)'s (STO:SCIB) Earnings Outlook?
Help shape the future of investing tools and receive a $20 prize! … The latest earnings release SciBase Holding AB (publ)'s (STO:SCIB) announced in December 2018 … that losses became smaller relative to the prrior year's level
Is SciBase Holding AB (publ) (STO:SCIB) A Financially Sound Company?
The direct benefit for SciBase Holding AB (publ) (STO:SCIB), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … Is SCIB right in choosing financial flexibility over lower cost of capital … Debt capital generally has lower cost of capital compared to equity funding.
Why SciBase Holding AB (publ)'s (STO:SCIB) CEO Salary Matters To You
At the time of writing our data says that SciBase Holding AB (publ) has a market cap of kr60m, and is paying total annual CEO compensation of kr2m. … We looked at a group of companies with market capitalizations under kr1.8b, and the median CEO compensation was kr2m. … As you can see, Simon Grant is paid more than the median CEO pay at companies of a similar size, in the same market
Who Owns Most Of SciBase Holding AB (publ) (STO:SCIB)?
In this article, I will take a quick look at SciBase Holding AB (publ)’s (STO:SCIB) recent ownership structure – an unconventional investing subject, but an important one. … Ownership structure of a company has been found to affect share performance over time. … Therefore, it is beneficial for us to examine SCIB's ownership structure in more detail.
Have Investors Priced In SciBase Holding AB (publ)'s (STO:SCIB) Growth?
SciBase Holding AB (publ) (STO:SCIB), a medical equipment company based in Sweden,. … A question to answer is whether SciBase Holding's current trading price of SEK6.75 reflective of the actual value of the? … Let’s take a look at SciBase Holding’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change
Where SciBase Holding AB (publ) (OM:SCIB) Stands In Terms Of Earnings Growth Against Its Industry
When SciBase Holding AB (publ) (OM:SCIB) released its most recent earnings update (31 March 2018), I compared it against two factor: its historical earnings track record, and the performance of its industry peers on average. … Being able to interpret how well SciBase Holding has done so far requires weighing its performance against a benchmark, rather than looking at a standalone number at a point in time. … SCIB is loss-making, with the most recent trailing twelve-month earnings of -kr40.51m (from 31 March 2018), which compared to last year has become.
Should You Be Content With SciBase Holding AB's (STO:SCIB) Earnings Growth?
View our latest analysis for SciBase Holding Commentary On SCIB's Past Performance I use the ‘latest twelve-month’ data, which annualizes the latest 6-month earnings release, or some times, the latest annual report is already the most recent financial data. … For SciBase Holding, its most recent earnings (trailing twelve month) is -KR42.46M, which, against the prior year's level, has become less negative. … OM:SCIB Income Statement Apr 12th 18 We can further examine SciBase Holding's loss by looking at what the industry has been experiencing over the past few years.
SciBase Holding AB (publ), a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The company offers Nevisense, a point-of-care detection device for non-visual detection of malignant melanoma. It serves public hospitals and private dermatology clinics. The company has a collaboration agreement with Swiss Institute of Allergy and Asthma Research. The company was founded in 1998 and is headquartered in Stockholm, Sweden.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.